These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12832347)

  • 1. Glargine insulin is not an alternative in insulin allergy.
    Durand-Gonzalez KN; Guillausseau N; Pecquet C; Gayno JP
    Diabetes Care; 2003 Jul; 26(7):2216. PubMed ID: 12832347
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin glulisine in the treatment of allergy to rapid acting insulin and its rapid acting analogs.
    Mollar-Puchades MA; Villanueva IL
    Diabetes Res Clin Pract; 2009 Jan; 83(1):e21-2. PubMed ID: 19070911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of insulin allergy in a 1-year-old infant with neonatal diabetes by lispro and glargine insulin.
    Kara C; Kutlu AO; Evliyaoglu O; Bilgili H; Yildirim N
    Diabetes Care; 2005 Apr; 28(4):983-4. PubMed ID: 15793215
    [No Abstract]   [Full Text] [Related]  

  • 4. Desensitization of allergy to human insulin and its analogs by administering insulin aspart and insulin glargine.
    Wu P; Ji C; Wang M; Zou S; Ge W
    Ann Endocrinol (Paris); 2013 Feb; 74(1):56-8. PubMed ID: 23351561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insulin allergy whose local/systemic reactions were reduced by desensitization with long-acting insulin analog, glargine].
    Tuboi M; Tsuchiya T; Taguchi R; Tanaka Y; Iwasaki Y; Hashimoto K; Kakizaki S; Okada S; Shimizu H; Mori M
    Nihon Naika Gakkai Zasshi; 2010 Jan; 99(1):133-5. PubMed ID: 20196485
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin glargine and the risk of cancer.
    Ahmed FA
    Cardiovasc J Afr; 2010; 21(1):49. PubMed ID: 20224847
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin allergy; desensitization with crystalline zinc-insulin and steroid tapering.
    Yokoyama H; Fukumoto S; Koyama H; Emoto M; Kitagawa Y; Nishizawa Y
    Diabetes Res Clin Pract; 2003 Sep; 61(3):161-6. PubMed ID: 12965105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glargine and lispro: two cases of mistaken identity.
    Adlersberg MA; Fernando S; Spollett GR; Inzucchi SE
    Diabetes Care; 2002 Feb; 25(2):404-5. PubMed ID: 11815523
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment with human analog (GlyA21, ArgB31, ArgB32) insulin glargine (HOE901) resolves a generalized allergy to human insulin in type 1 diabetes.
    Moriyama H; Nagata M; Fujihira K; Yamada K; Chowdhury SA; Chakrabarty S; Jin Z; Yasuda H; Ueda H; Yokono K
    Diabetes Care; 2001 Feb; 24(2):411-2. PubMed ID: 11213905
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin glargine and cancer--an unsubstantiated allegation.
    Garg SK; Hirsch IB; Skyler JS
    Diabetes Technol Ther; 2009 Aug; 11(8):473-6. PubMed ID: 19591544
    [No Abstract]   [Full Text] [Related]  

  • 11. A possible link between insulin glargine and malignancy: the facts.
    Mollentze WF
    Cardiovasc J Afr; 2009; 20(4):216-8; discussion 218-9. PubMed ID: 19701528
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of lipoatrophy with insulin glargine: long-acting insulin analogs are not exempt from this complication.
    Ampudia-Blasco FJ; Girbes J; Carmena R
    Diabetes Care; 2005 Dec; 28(12):2983. PubMed ID: 16306570
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial: glargine, a new long-acting insulin analog for diabetic cats.
    Rand J
    J Vet Intern Med; 2006; 20(2):219-20. PubMed ID: 16594574
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin glargine and malignancy: an unwarranted alarm.
    Pocock SJ; Smeeth L
    Lancet; 2009 Aug; 374(9689):511-3. PubMed ID: 19616841
    [No Abstract]   [Full Text] [Related]  

  • 15. Type III allergy to insulin detemir.
    Darmon P; Castera V; Koeppel MC; Petitjean C; Dutour A
    Diabetes Care; 2005 Dec; 28(12):2980. PubMed ID: 16306568
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe insulin allergy successfully treated with continuous subcutaneous insulin infusion.
    Fujikawa T; Imbe H; Date M; Go Y; Kitaoka H
    Diabetes Res Clin Pract; 2012 Aug; 97(2):e31-3. PubMed ID: 22609054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperpigmentation due to insulin allergy.
    Neki NS; Gupta SN; Mani T; Gupta H
    Natl Med J India; 2014; 27(3):183. PubMed ID: 25668097
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin resistance and increased risk for malignant neoplasms: confounding of the data on insulin glargine.
    Nagel JM; Mansmann U; Wegscheider K; Röhmel J
    Diabetologia; 2010 Jan; 53(1):206-8. PubMed ID: 19774358
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin glargine controversy: a tribute to the editorial team at Diabetologia.
    Butler PC
    Diabetes; 2009 Nov; 58(11):2427-8. PubMed ID: 19875618
    [No Abstract]   [Full Text] [Related]  

  • 20. Human insulin analog insulin aspart does not cause insulin allergy.
    Yasuda H; Nagata M; Moriyama H; Fujihira K; Kotani R; Yamada K; Ueda H; Yokono K
    Diabetes Care; 2001 Nov; 24(11):2008-9. PubMed ID: 11679481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.